Torthaí cuardaigh - Ran Reshef

Beachtaigh na torthaí
  1. 1
    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report de réir Tyler Ruemmele, Rodney Macedo, Mark N. Stein, Hei Ton Chan, Markus Y. Mapara, Céline Jacquemont, Ran Reshef

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients

    Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients de réir Ran Reshef, Marlise R. Luskin, Malek Kamoun, Saran Vardhanabhuti, J E Tomaszewski, Edward A. Stadtmauer, David Porter, Daniel F. Heitjan, De.E. Tsai

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation

    Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation de réir Alex Ganetsky, Arpita Shah, Todd A. Miano, W-T Hwang, J. He, Alison W. Loren, Elizabeth O. Hexner, Noelle V. Frey, David L. Porter, Ran Reshef

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

    Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★ de réir Ran Reshef, Saran Vardhanabhuti, Marlise R. Luskin, Daniel F. Heitjan, Denis Hadjiliadis, Simin Göral, Karen Krok, Lee R. Goldberg, David Porter, Edward A. Stadtmauer, Daniel Tsai

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

    NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT de réir Mobin Karimi, Jerrod L. Bryson, Lee P. Richman, Andrew D. Fesnak, Theresa M. Leichner, Atsushi� Satake, Robert H. Vonderheide, David H. Raulet, Ran Reshef, Taku Kambayashi

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

    Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis de réir Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David Porter, Ran Reshef

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

    The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder de réir Marlise R. Luskin, Daniel S. Heil, Kay See Tan, Soo Jin Choi, Edward A. Stadtmauer, Stephen J. Schuster, David L. Porter, Robert H. Vonderheide, Adam Bagg, Daniel F. Heitjan, Donald E. Tsai, Ran Reshef

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity

    Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity de réir Shan He, Yongnian Liu, Lijun Meng, Hongxing Sun, Ying Wang, Yun Ji, Janaki Purushe, Pan Chen, Changhong Li, Jozef Madžo, Jean–Pierre J. Issa, Jonathan Soboloff, Ran Reshef, Bethany B. Moore, Luca Gattinoni, Yi Zhang

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning

    Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning de réir Ran Reshef, Elizabeth O. Hexner, Alison W. Loren, Noelle V. Frey, Edward A. Stadtmauer, Selina M. Luger, James K. Mangan, Saar Gill, Pavel Vassilev, Kathryn A. Lafferty, Jacqueline Smith, Vivianna M. Van Deerlin, Rosemarie Mick, David Porter

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

    Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis de réir Éric Lefebvre, Graeme Moyle, Ran Reshef, Lee P. Richman, Melanie Thompson, Hong Feng, Hsin-l Chou, Taishi Hashiguchi, Craig F. Plato, Dominic Poulin, Toni L. Richards, Hiroyuki Yoneyama, Helen Jenkins, Grushenka H.I. Wolfgang, Scott L. Friedman

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study

    Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study de réir Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros J. Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael A. Pratta, Rodica Morariu-Zamfir, John F. DiPersio

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial

    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial de réir Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Usama Gergis, Martin Guiterrez, Ran Reshef, Sumit K. Subudhi, Céline Jacquemont, Joseph Senesac, J. Henri Bayle, Charity D. Scripture, Monica Sheila Chatwal, Mehmet Asım Bilen, Walter M. Stadler, Carlos Becerra

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation

    The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation de réir Lijun Meng, Zhenjiang Bai, Shan He, Kazuhiro Mochizuki, Yongnian Liu, Janaki Purushe, Hongxing Sun, Jian Wang, Hideo Yagita∥, Shin Mineishi, Henry C. Fung, Gregory A. Yanik, Roberto Caricchio, Xiaoxuan Fan, Lisa Crisalli, Elizabeth O. Hexner, Ran Reshef, Yanyun Zhang, Yi Zhang

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

    Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease de réir Ran Reshef, Selina M. Luger, Elizabeth O. Hexner, Alison W. Loren, Noelle V. Frey, Sunita D. Nasta, Steven C. Goldstein, Edward A. Stadtmauer, Jacqueline Smith, S. Bailey, Rosemarie Mick, Daniel F. Heitjan, Stephen G. Emerson, James A. Hoxie, Robert H. Vonderheide, David Porter

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

    High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning de réir Ran Reshef, Austin P. Huffman, Amy Gao, Marlise R. Luskin, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Taku Kambayashi, Alison W. Loren, Selina M. Luger, James K. Mangan, Sunita D. Nasta, Lee P. Richman, Mary Sell, Edward A. Stadtmauer, Robert H. Vonderheide, Rosemarie Mick, David Porter

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide de réir Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel‐Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Álvaro Urbano-Ispízua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplantation

    KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplant... de réir Saad Z. Usmani, Krina K. Patel, Parameswaran Hari, Jesús G. Berdeja, Melissa Alsina, Ravi Vij, Noopur Raje, Xavier Leleu, Madhav V. Dhodapkar, Ran Reshef, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Revathi Ananthakrishnan, Chiara Greggio, Linda Favre-Kontula, Lars Sternas, Jesús F. San Miguel

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

    Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol de réir Sarah Nikiforow, Jennifer Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin T. Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E. Prockop

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

    Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation de réir Neema P. Mayor, Tao Wang, Stephanie J. Lee, Michelle Kuxhausen, Cynthia Vierra‐Green, Dominic J. Barker, Jeffery J. Auletta, Vijaya Raj Bhatt, Shahinaz M. Gadalla, Loren Gragert, Yoshihiro Inamoto, Gerald P. Morris, Sophie Paczesny, Ran Reshef, Olle Ringdén, Bronwen E. Shaw, Peter J. Shaw, Stephen R. Spellman, Steven G. E. Marsh

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

    Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Tria... de réir Marcelo C. Pasquini, Brent R. Logan, Richard J. Jones, Amin M. Alousi, Frederick R. Appelbaum, Javier Bolaños‐Meade, Mary E.D. Flowers, Sergio Giralt, Mary M. Horowitz, David A. Jacobsohn, John Koreth, John E. Levine, Leo Luznik, Richard T. Maziarz, Adam Mendizabal, Steven Z. Pavletic, Miguel‐Angel Perales, David Porter, Ran Reshef, Daniel J. Weisdorf, Joseph H. Antin

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: